Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Oct 30.
doi: 10.1007/s40273-025-01551-7. Online ahead of print.

Comment on "Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective" by Marten J. Poley et al

Affiliations
Comment

Comment on "Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective" by Marten J. Poley et al

Alexander Allen et al. Pharmacoeconomics. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: The authors declare no conflicts of interest in relation to this work. Author Contributions: All authors contributed to the manuscript conception and design and were involved with the work of the EAG. Data availability: Committee discussion and committee papers, including EAG reports, for published guidance are available through the NICE website.

Comment on

References

    1. Poley MJ, et al. Cost comparisons in NICE technology appraisals: an external assessment group perspective. Pharmacoeconomics. 2025. https://doi.org/10.1007/s40273-025-01522-y . - DOI - PubMed
    1. Tirrell Z, et al. Bring out your dead: a review of the cost minimisation approach in health technology assessment submissions to the Australian Pharmaceutical Benefits Advisory Committee. Pharmacoeconomics. 2024;42(11):1287–300. - DOI - PubMed - PMC
    1. National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual. NICE process and methods [PMG36]. 2022 31 Oct 2023; Available from: https://www.nice.org.uk/process/pmg36 .
    1. National Institute for Health and Care Excellence (NICE). Cost comparison. Addendum to the Guide to the methods of technology appraisal. London: NICE; 2018.
    1. National Institute for Health and Care Excellence (NICE). Bimekizumab for treating axial spondyloarthritis. Technology appraisal guidance. Reference number:TA918. 2023; Available from: https://www.nice.org.uk/guidance/ta918 .

LinkOut - more resources